Dyne Therapeutics, Inc. - Common Stock, $0.0001 par value per share (DYN)

113 filings reported holding DYN - Dyne Therapeutics, Inc. - Common Stock, $0.0001 par value per share as of Q3 2022.
Dyne Therapeutics, Inc. - Common Stock, $0.0001 par value per share (DYN) has 100 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 44,533,854 shares of 141,783,702 outstanding shares and own 31% of the company stock.
Largest 10 shareholders include Atlas Venture Life Science Advisors, LLC (8,934,902 shares), MPM ASSET MANAGEMENT LLC (4,951,303 shares), Deep Track Capital, LP (3,184,200 shares), CITADEL ADVISORS LLC (2,922,372 shares), BlackRock Inc. (2,525,067 shares), WASATCH ADVISORS INC (2,292,268 shares), Logos Global Management LP (2,287,321 shares), Vida Ventures Advisors, LLC (2,220,034 shares), FRANKLIN RESOURCES INC (1,782,818 shares), and Point72 Asset Management, L.P. (1,497,631 shares).
This table shows the top 100 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.